Novel Malaria Treatment Shows Positive Results for Infants <5kg: Novartis & Medicines for Malaria Venture
Novartis and Medicines for Malaria Venture (MMV) have unveiled encouraging results from their phase II/III CALINA trial, indicating that a newly formulated version of Coartem® (artemether-lumefantrine) tailored for infants weighing…
EU Approves Vaidya as Additional Therapy for Adults with PNH and Persistent Haemolytic Anaemia Despite Rovelizumab or Eculizumab Treatment
Voydeya (danicopan) Receives EU Approval as Supplemental Treatment for Adults with PNH and Residual Hemolytic Anemia Voydeya (danicopan) has gained approval in the European Union (EU) to be used alongside…
Join Allergan Aesthetics in Becoming the Ambassador for BOTOX® Cosmetic and Their Leading Brands
Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), is extending an invitation to consumers to participate in future campaigns featuring their flagship brands, such as BOTOX® Cosmetic, the JUVÉDERM® Collection…
Positive Phase 2 Results for NBI-1065845 in Adult Major Depression
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has unveiled positive top-line results from its Phase 2 SAVITRI™ trial. This study, employing a randomized, double-blind, and placebo-controlled design, evaluated the efficacy and safety…
Tomi Pitkäniemi and Nikolas Kusto Discuss How Effective Automation Boosts Medicinal Quality and Orion’s Competitive Edge
When a patient chooses a medication crafted by Orion, they can trust they’re receiving precisely the indicated dosage of active ingredients,” highlights Tomi Pitkäniemi, Automation Manager, underlining the critical role…
Lupin’s Aurangabad Manufacturing Facility Granted EIR by U.S. FDA
Lupin, a global pharmaceutical giant, proudly announces the reception of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its manufacturing facility in…
Moderna Secures Deal to Provide 12.5 Million COVID-19 Vaccines for Brazil’s National Vaccination Drive
Moderna, Inc. (NASDAQ: MRNA) has announced a significant milestone in its global efforts to combat COVID-19 by securing a contract with Brazil’s Ministry of Health (Ministério da Saúde). The contract…
Our commitment to reducing plastic waste
In April, we annually commemorate Earth Day, underscoring the collaborative endeavor required to forge a healthier environment for the forthcoming generations. This year’s Earth Day theme, “Planet versus Plastics,” spotlights…
Bristol Myers Squibb & Cellares Strike $380M Deal to Boost CAR T Cell Therapy Production
Bristol Myers Squibb (NYSE: BMY) and Cellares, the pioneering Integrated Development and Manufacturing Organization (IDMO) dedicated to cell therapy manufacturing, have announced a significant worldwide capacity reservation and supply agreement.…
European Commission Clears Pfizer’s EMBLAVEO® for Multidrug-Resistant Infections
Pfizer Inc. (NYSE: PFE) has received approval from the European Commission (EC) for EMBLAVEO® (aztreonam-avibactam), expanding treatment options for adult patients facing complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including…
Lilly Purchases New Injectable Medicine Plant from Nexus Pharmaceuticals
Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a prominent sterile manufacturer in the…
Astellas Verifies Unfavourable District Court Ruling on Preliminary Injunction Against Lupin and Zydus’ MyrbetriqTM Generics
Astellas Pharma Inc. has confirmed that the U.S. District Court for the District of Delaware has issued a Report and Recommendation advising against granting Astellas’ motion for a preliminary injunction.…